From Jeff Childers

The New York Times — of all places — ran a surprising article last week headlined, “Trying to Solve a Covid Mystery: Africa’s Low Death Rates.” It’s a mystery! The sub-headline reads, “The coronavirus was expected to devastate the continent, but higher-income and better-prepared countries appear to have fared far worse.” Well, well, well. The Times reported population studies showed that about two-thirds of the population in most sub-Saharan countries already have Covid antibodies. Since only 14 percent of the population has received any kind of Covid vaccination, the antibodies must be overwhelmingly from natural infection. The bottom line is, the experts have no ideas why low-jabbed Africa is doing so much better than countries with well-developed corporate hospital systems and high jab rates. No ideas at all. The experts are baffled. Again. The article explored and rejected a series of possibilities, like whether a large number of deaths had somehow gone unreported in Africa. But, according to an expert cited for the story, “it was clear there had been no tide of desperately sick people.” Because of previous scares like Ebola, Africa has one of the most highly-developed infection tracking systems in the world. It’s not like they aren’t keeping track. The story concludes that Africans should STILL get the shots, of course. “Because at this point, it’s not for those people: It’s to try to prevent new variants,” an expert explained. “A new variant as infectious as Omicron but more lethal than Delta could yet emerge, he warned, leaving Africans vulnerable unless vaccination rates increased significantly.” Sure. New variants. You never know. Jabs now, jabs later, jabs forever.”> The New York Times — of all places — ran a surprising article last week headlined, “Trying to Solve a Covid Mystery: Africa’s Low Death Rates.” It’s a mystery! The sub-headline reads, “The coronavirus was expected to devastate the continent, but higher-income and better-prepared countries appear to have fared far worse.” Well, well, well. The Times reported population studies showed that about two-thirds of the population in most sub-Saharan countries already have Covid antibodies. Since only 14 percent of the population has received any kind of Covid vaccination, the antibodies must be overwhelmingly from natural infection. The bottom line is, the experts have no ideas why low-jabbed Africa is doing so much better than countries with well-developed corporate hospital systems and high jab rates. No ideas at all. The experts are baffled. Again. The article explored and rejected a series of possibilities, like whether a large number of deaths had somehow gone unreported in Africa. But, according to an expert cited for the story, “it was clear there had been no tide of desperately sick people.” Because of previous scares like Ebola, Africa has one of the most highly-developed infection tracking systems in the world. It’s not like they aren’t keeping track. The story concludes that Africans should STILL get the shots, of course. “Because at this point, it’s not for those people: It’s to try to prevent new variants,” an expert explained. “A new variant as infectious as Omicron but more lethal than Delta could yet emerge, he warned, leaving Africans vulnerable unless vaccination rates increased significantly.” Sure. New variants. You never know. Jabs now, jabs later, jabs forever.